Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
Clinical trial NCT06504719 · COMPLETED
Trial details
- NCT number
- NCT06504719
- Sponsor
- Hellenic Cooperative Oncology Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-06-01
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.